Should we use appetite stimulants for malnourished elderly patients?

Research Projects

Organizational Units

Journal Issue

Abstract

Only 1 appetite stimulate, megestrol acetate oral suspension (Megace) at 400 mg or 800 mg daily, has been studied in this population. The data show only limited benefit, mixed outcomes, and potential harm (strength of recommendation: B, based on small, randomized, controlled trials).

Table of Contents

DOI

PubMed ID

Degree

Thesis Department

Rights

OpenAccess.

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.